SS INNOVATIONS INTERNATIONAL INC. COMMON STOCK
NASDAQ: SSII (SS Innovations International In)
Last update: 17 hours ago5.34
0.17 (3.29%)
Previous Close | 5.17 |
Open | 5.20 |
Volume | 92,557 |
Avg. Volume (3M) | 215,265 |
Market Cap | 1,033,845,376 |
Price / Sales | 44.14 |
Price / Book | 25.49 |
52 Weeks Range | |
Earnings Date | 4 Sep 2025 - 8 Sep 2025 |
Profit Margin | -67.73% |
Operating Margin (TTM) | -115.65% |
Diluted EPS (TTM) | -0.080 |
Quarterly Revenue Growth (YOY) | 40.80% |
Total Debt/Equity (MRQ) | 25.78% |
Current Ratio (MRQ) | 3.17 |
Operating Cash Flow (TTM) | -12.93 M |
Levered Free Cash Flow (TTM) | -14.06 M |
Return on Assets (TTM) | -19.93% |
Return on Equity (TTM) | -55.43% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Bearish | Bearish |
Medical Devices (Global) | Bearish | Bearish | |
Stock | SS Innovations International In | - | - |
AIStockmoo Score
Analyst Consensus | -2.0 |
Insider Activity | NA |
Price Volatility | 2.0 |
Technical Moving Averages | 1.0 |
Technical Oscillators | -5.0 |
Average | -1.00 |
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Mid Growth |
% Held by Insiders | 83.38% |
No data within this time range.
Date | Type | Details |
---|---|---|
16 Jun 2025 | Announcement | SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company’s SSi Mantra 3 Surgical Robotic System |
02 Jun 2025 | Announcement | SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025 |
14 May 2025 | Announcement | SS Innovations Reports First Quarter 2025 Financial Results |
08 May 2025 | Announcement | SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications |
05 May 2025 | Announcement | SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends |
02 May 2025 | Announcement | SS Innovations Announces Chief Financial Officer Transition |
24 Apr 2025 | Announcement | SS Innovations to Uplist to Nasdaq |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |